|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03195543 |
|
Date of registration:
|
08/06/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
|
|
Scientific title:
|
Assessment of Blood Coagulation Disorders in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. |
|
Date of first enrolment:
|
March 12, 2015 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03195543 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Greece
| | | | | | | |
|
Contacts
|
|
Name:
|
Eleni Vrigkou, MD, MSc |
|
Address:
|
|
|
Telephone:
|
0030-2105832179 |
|
Email:
|
elenivrigkou@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Iraklis Tsagkaris, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National and Kapodistrian University of Athens |
|
|
Name:
|
Argyrios Tsantes, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National and Kapodistrian University of Athens |
|
|
Name:
|
Eleni Vrigkou, MD, MSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National and Kapodistrian University of Athens |
|
|
Name:
|
Eleni Vrigkou, MD, MSc |
|
Address:
|
|
|
Telephone:
|
00302105832179 |
|
Email:
|
elenivrigkou@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Apostolos Armaganidis, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National and Kapodistrian University of Athens |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Pulmonary Arterial Hypertension,
- Chronic Thromboembolic Pulmonary Hypertension.
Exclusion Criteria:
- renal insufficiency,
- hepatic insufficiency,
- thyroid dysfunction,
- malignancy,
- active infections,
- receiving anticoagulant or antiplatelet therapy,
- history of hemostatic disorders irrelevant to their primary disease,
- abnormal red blood counts.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Chronic Thromboembolic Pulmonary Hypertension
|
|
Pulmonary Artery Hypertension
|
|
Intervention(s)
|
|
Diagnostic Test: Rotational thromboelastometry
|
|
Diagnostic Test: Platelet function analyzer-100
|
|
Diagnostic Test: Endogenous thrombin potential
|
|
Diagnostic Test: Light transmission aggregometry
|
|
Primary Outcome(s)
|
|
PFA-100 in detection of platelet abnormalities in PAH and CTEPH patients.
[Time Frame: 6 months]
|
|
Endogenous thrombin potential in detection of thrombin abnormalities in PAH and CTEPH patients.
[Time Frame: 6 months]
|
|
ROTEM in detection of coagulation abnormalities in PAH and CTEPH patients.
[Time Frame: 6 months]
|
|
Light transmission aggreggometry in detection of platelet abnormalities in PAH and CTEPH patients.
[Time Frame: 6 months]
|
|
Secondary ID(s)
|
|
???410/17-9-14
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|